DAN insider plans sale via Morgan Stanley: 11,728 shares disclosed

Rhea-AI Filing Summary

Dana Incorporated (DAN) filed a Form 144 disclosing a proposed sale of 11,728 common shares with an aggregate market value of $218,692.02, to be executed approximately on 08/13/2025 through Morgan Stanley Smith Barney LLC. The filing reports 131,153,633 shares outstanding for the issuer and identifies the broker by name and address.

The shares to be sold were acquired as restricted stock vestings under a registered plan on 02/10/2023 (6,279 shares), 02/13/2025 (2,345 shares), 02/14/2025 (1,667 shares) and 02/15/2025 (1,437 shares), with consideration listed as services rendered. The filing notes nothing to report for securities sold during the past three months and includes the usual representation that the seller is unaware of undisclosed material adverse information about the issuer.

Positive

• Full Rule 144 disclosure with broker name, share counts, aggregate market value, and acquisition details provided
• No sales reported in the prior three months per the filing

Negative

• Proposed insider sale of 11,728 shares (aggregate value $218,692.02) is disclosed
• Sale reduces insider holdings acquired via restricted stock vesting (payment listed as services rendered)

Insights

Securities / Compliance Analyst

TL;DR: Routine Rule 144 disclosure of a modest insider sale through an institutional broker; details show restricted-stock origin and compliance.

The Form 144 documents a proposed sale of 11,728 common shares valued at $218,692.02 to be executed via Morgan Stanley Smith Barney LLC on approximately 08/13/2025. Acquisition history ties the holdings to restricted-stock vestings under a registered plan on specific dates in 2023 and 2025, with payment characterized as services rendered. The filing also reports no sales in the prior three months and includes the standard seller representation regarding material adverse information. For compliance monitoring, the record is complete with broker, share counts, acquisition dates, and consideration noted.

Corporate Governance Expert

TL;DR: Transparent insider reporting; transaction size is small relative to outstanding shares and appears procedural rather than material.

The disclosure provides necessary transparency about an insider sale under Rule 144, listing the broker, exact share quantities, aggregate dollar value, and acquisition provenance (restricted stock vestings). The cumulative vesting entries sum to the total shares reported for sale, and the filing confirms no recent sales during the three-month lookback. From a governance perspective, the submission meets disclosure requirements and records the seller's attestation about lack of undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11728	218692.02	131153633	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2023	Restricted stock vesting under a registered plan	Issuer			6279	02/10/2023	Services Rendered
Common	02/15/2025	Restricted stock vesting under a registered plan	Issuer			1437	02/15/2025	Services Rendered
Common	02/13/2025	Restricted stock vesting under a registered plan	Issuer			2345	02/13/2025	Services Rendered
Common	02/14/2025	Restricted stock vesting under a registered plan	Issuer			1667	02/14/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Dana (DAN) Form 144 disclose?

The filing discloses a proposed sale of 11,728 common shares valued at $218,692.02, to be sold approximately on 08/13/2025 through Morgan Stanley Smith Barney LLC.

How were the shares acquired that are being sold in the DAN Form 144?

The shares were acquired as restricted stock vestings under a registered plan on 02/10/2023 (6,279), 02/13/2025 (2,345), 02/14/2025 (1,667), and 02/15/2025 (1,437).

What broker will handle the proposed sale listed in the Form 144 for DAN?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the Form 144 report any securities sold by the seller in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What representation does the seller make in the Form 144?

The seller represents by signing the notice that they do not know any material adverse information about the current and prospective operations of the issuer that has not been publicly disclosed.